XNAS
VRXA
Jun 24, Last price
2.30USD
1D
-20.96%
IPO
-88.50%
Name
Veraxa Biotech AG
Chart & Performance
P/E
—
P/S
—
EPS
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
Net income
CFO
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]
Valuation
No data to show